2026-525208-90-00招募中1 期
A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Immunic AG
- 入组人数
- 26
- 试验地点
- 3
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years(18-64 Years)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Andreas Muehler
Scientific
Immunic AG
研究点 (3)
Loading locations...
相似试验
已完成
1 期
Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.NCT07322991Il-Yang Pharm. Co., Ltd.43
招募中
1 期
A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib TabletNCT07374224Guangzhou Lupeng Pharmaceutical Company LTD.28
已完成
1 期
A Phase I, open-label, fixed sequence drug interaction study in healthy subjects to investigate the effect of a 40 mg deucrictibant tablet administered once daily on the pharmacokinetics of the P-gp substrate digoxin and the BCRP substrate rosuvastatin, administered as a drug cocktailHereditary angioedema2024-514713-35-00Pharvaris Netherlands B.V.14
尚未招募
1 期
Study on the Drug Interaction Between Buagafuran and VoriconazoleNCT07457203Beijing Union Pharmaceutical Factory Ltd18
尚未招募
2 期
IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic CancerPancreatic CancerNCT07415525Zhejiang University40
